# A case report of Castleman disease variant of POEMS syndrome presenting with prominent polyserositis and renal impairment

**Authors:** Congcong Min, Ailing Liu, Yushuang Xu, Yanan Yu, Yonghong Xu, Tao Mao, Xueli Ding

PMC · DOI: 10.3389/fmed.2025.1537944 · 2025-06-16

## TL;DR

A rare case of POEMS syndrome variant with Castleman disease is reported, presenting with fluid buildup and kidney issues, and responding to chemotherapy and dialysis.

## Contribution

This paper presents a rare case of Castleman disease variant of POEMS syndrome without M protein, highlighting diagnostic challenges and treatment response.

## Key findings

- The patient exhibited polyserositis and renal impairment without monoclonal protein.
- Diagnosis was confirmed via lymph node biopsy revealing Castleman disease.
- Treatment with VPD chemotherapy and hemodialysis improved effusions and renal function.

## Abstract

POEMS syndrome is a rare hematologic disorder related to plasma cell dyscrasia. The Castleman disease variant of POEMS syndrome is extremely rare and often misdiagnosed. In this study, we aim to present a noteworthy case of POEMS syndrome mainly manifested as multiple pleural effusion and renal impairment without M protein.

A 47-year-old woman was admitted to the hospital with a 7-month history of lower extremity edema and 3 months of abdominal distension. Computed tomography revealed poly-serosal effusion and hepatosplenomegaly, while ultrasound showed multiple superficial lymphadenopathies. Serum protein electrophoresis and bone biopsy indicated no evidence of monoclonal plasma cell proliferation. Pathological results obtained from lymph node biopsy revealed Castleman disease (CD). The patient was ultimately diagnosed with the Castleman disease variant of POEMS syndrome without M protein. Renal function gradually declined in the later stages of the disease. After transferring to another hospital, the patient received a VPD chemotherapy regimen (Pomalidomide, Bortezomib, and Dexamethasone) and hemodialysis. Effusions in multiple serosal cavities were reduced, and renal function improved significantly following active treatment.

POEMS syndrome without M protein is often misdiagnosed as other conditions. In patients presenting with multiple systemic manifestations, the possibility of POEMS syndrome or CD should be considered.

## Linked entities

- **Chemicals:** Pomalidomide (PubChem CID 134780), Bortezomib (PubChem CID 387447), Dexamethasone (PubChem CID 5743)
- **Diseases:** POEMS syndrome (MONDO:0017364), Castleman disease (MONDO:0015564), plasma cell dyscrasia (MONDO:0004959)

## Full-text entities

- **Genes:** MYOM2 (myomesin 2) [NCBI Gene 9172] {aka TTNAP}
- **Diseases:** serosal effusion (MESH:D012700), CD (MESH:D005871), hepatosplenomegaly (MESH:C535727), plasma cell dyscrasia (MESH:D010265), lymphadenopathies (MESH:D008206), polyserositis (MESH:D010505), renal impairment (MESH:D007674), abdominal distension (MESH:D000007), lower extremity edema (MESH:D004487), hematologic disorder (MESH:D006402), POEMS syndrome (MESH:D016878), pleural effusion (MESH:D010996)
- **Chemicals:** Pomalidomide (MESH:C467566), Bortezomib (MESH:D000069286), Dexamethasone (MESH:D003907)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12206744/full.md

---
Source: https://tomesphere.com/paper/PMC12206744